Source - LSE Regulatory
RNS Number : 9372Z
Henderson European Focus Trust PLC
26 May 2021
 

Legal Entity Identifier: 213800GS89AL1DK3IN50

 

HENDERSON EUROPEAN FOCUS TRUST PLC (the "Company")

 

Unaudited results for the half-year ended 31 March 2021

 

This announcement contains regulated information

 

Investment objective

The Company seeks to maximise total return (a combination of income and capital growth) from a portfolio of stocks listed in Europe.

 

Performance highlights

•      Net asset value ("NAV") per ordinary share total return1 (with dividends reinvested) of 13.6% compared to the benchmark2 return of 11.9%

•      Share price3 total return (with dividends reinvested) of 17.2%

•      Interim dividend of 9.60p per share declared (2020: 9.60p)

 

Total return performance to 31 March 2021 (with dividends reinvested)

 

6 months

%

1 year

%

3 years

%

5 years

%

10 years

 %

NAV1

13.6

42.3

34.8

76.4

194.1

Benchmark index2

11.9

34.9

27.3

69.7

114.4

Average AIC sector NAV4

12.0

41.6

34.1

80.0

165.3

Share price3

17.2

50.3

23.4

71.8

198.3

Average AIC sector share price4

15.5

48.5

34.3

82.6

181.3

 

1 Net asset value ("NAV") total return per ordinary share (with dividends reinvested)

2 FTSE World Europe ex UK Index on a total return basis in Sterling terms

3 Share price total return (with dividends reinvested) using mid-market closing price

4 Association of Investment Companies ("AIC") Europe sector of eight companies

 

Sources: Morningstar Direct, Refinitiv Datastream and Janus Henderson

 

Financial highlights

 

At 31 March 2021

(unaudited)

At 30 September 2020

(audited)

Shareholders' funds

 

 

Net assets

£345.3m

£308.2m

NAV per ordinary share

1,615.00p

1,441.20p

Share price

1,455.00p

1,260.00p

Gearing at period end

0.2%

0.6%

 

 

 

 

Half-year ended

31 March 2021

(unaudited)

Year ended

30 September 2020

(audited)

Total return to equity shareholders

 

 

Revenue return after taxation (£'000)

Capital return after taxation (£'000)

1,924

5,184

39,798

12,146

Total return

41,722

17,330

Total return per ordinary share

 

 

Revenue

9.00p

24.13p

Capital

186.12p

56.54p

Total return

195.12p

80.67p

  

 

INTERIM MANAGEMENT REPORT

 

Chair's Statement

 

With the rapid authorisation of a number of effective vaccines, markets the world over have responded positively to renewed optimism in recent months on all fronts: social, economic and financial. Continental Europe has been no exception even though, as well publicised, the vaccine roll-out programme has been slower than in other major economies. The good news is that the economic data is coming through stronger than expected and the feared sharp recession has been relatively short lived, with the retail consumer in particular expected to be surprisingly resilient as job losses have been below expectations and support measures substantial. Expectations of inflation, however, remain in low positive territory with the first grants and loans from last year's landmark €750bn spending package expected to be made by the EU Commission this summer. Trading updates coming from corporates are generally more upbeat than anticipated and European stock markets have responded positively.

 

Performance

In the six months to 31 March 2021, the Company's NAV total return per ordinary share rose by 13.6% to 1,615 pence, compared to an increase of 11.9% in the Company's benchmark, the FTSE World Europe ex UK index. The Company's share price total return rose by 17.2% to 1,455 pence, as the discount narrowed from 12.6% at 30 September 2020 to 9.9% at 31 March 2021. Gearing remains at the lower end of its range at just under 0.2% of net assets at the period end and so performance was largely achieved through active investing - further detail of which is in our Fund Managers' Report.

 

Revenue and dividend

A maintained interim dividend of 9.6 pence per ordinary share (2020: 9.6 pence) will be paid on 25 June 2021 to shareholders on the register on 4 June 2021. The shares will be marked ex-dividend on 3 June 2021.

 

Future Board changes

We are well underway in a process to recruit a new Board member. Having undertaken both our annual Board evaluation and held a strategy session in the first calendar quarter of 2021, the Board has decided that broadening its membership would be beneficial and we expect to make an announcement in the relatively near future. The Board is using external consultants in finding suitable candidates for our succession.

 

Outlook

Looking forward, we think there are many reasons to be optimistic about the prospects for continental European companies. After a decade of austerity, the EU Commission response to the pandemic has clearly had to change: unprecedented fiscal and monetary support measures, allied to encouraging corporate news has underpinned a recovery in markets. Valuations are high but not excessive, certainly in the context of the US stock valuations, and whilst some inflation is forecast it is not high enough to derail average equity valuations although those at the 'growthier' end of the style spectrum may well come in for more scrutiny.

 

We expect this market environment to suit the Company as our 'all-weather' approach avoids ascribing rigid labels of 'value' or 'growth' to our investment style. This has allowed the emphasis within the portfolio to change from 12 months ago: having had an economic recovery bias led by industrials in summer 2020, the portfolio now favours a bias towards beneficiaries of the much anticipated 're-opening' of economies, led by the consumer.

 

Finally, investors are realising that many European companies are the leading the way in providing solutions for many of the challenges we face in providing for a more sustainable future and are rightly starting to pay more attention to the changes underway. The Company's investment process - as we described more fully in the Annual Report - is very much focused on identifying and responding to that change.

 

Vicky Hastings

Chair

26 May 2021

 

 

Fund Managers' Report

 

In writing this report twelve months ago, we found ourselves in the eye of the Covid-19 storm and its first devastating wave of infections. One year later and, courtesy of the wonders of human ingenuity, we can see and feel the beginning of the end of a period which has dealt the severest of challenges. Of course, financial markets, by their very nature, anticipate economic and financial developments. In this respect the past six - indeed twelve - months have been no exception.

 

In the Company's most recent Annual Report to the year ended 30 September 2020, we described, in some detail, how we seek to commit capital on behalf of shareholders. Hopefully, our overriding belief in pragmatism, shone from that report. It is exactly this characteristic of open-mindedness that, we believe, has been a requisite since the moment Covid-19 struck. Indeed, a glance at the graphic in the half-year update underscores this point: as equity markets have 'broadened out', beyond the narrow leadership of 'growth' stocks, your Company has continued to prosper: a demonstration of our mantra; that we should never be dictated to or constrained by an investing 'style'. The two charts shown in the update for the six months ended 31 March 2021 illustrate graphically this return to favour of 'value' stocks, particularly over the previous six months.

 

Shortly after the pandemic came to the shores of Europe, we identified the ingredients that would lead to a V-shaped recovery in the industrial world. In a nutshell, those ingredients included naturally occurring lows in the corporate inventory and capital expenditure cycles. The pandemic served to aggravate those lows, driving them yet deeper. Then came the quite extraordinary monetary stimulus from central banks worldwide, followed, to varying degrees, by fiscal expansion. The resultant recovery in demand for industrial goods, as factories and construction sites quickly reopened, has played to our strategy.

 

Then, as calendar 2020 drew to a close and Europe was suffering from a second wave of infections, we drew succour from the unequivocally excellent vaccine data. This encouraged us to strengthen our view that a second V-shape is likely: this time in the consumer sphere. During the six-month period under review, we tilted the portfolio towards the consumer discretionary sector. Notwithstanding, at times, hysterical media and political rhetoric concerning vaccine rollouts, vaccine efficacy and even vaccine nationalism, we have resolutely trusted the data. Thus, we have not been swayed in building the portfolio's positions in stocks we consider strong reopening beneficiaries. Prime examples include Adidas, Amadeus, Carlsberg, Daimler, Essilor Luxottica, Inditex, Mowi, Ryanair and Stellantis.

 

The Company's optimistic positioning for the 'reopening' can be illuminated through that familiar, but temporarily elusive, modern ritual: the summer holiday. It is quite likely that you will unwittingly book your flights and accommodation using the Amadeus Global Distribution System. You may well fly to your destination with Ryanair, or a different airline on an Airbus A320 jet. A new holiday wardrobe might include clothes from Zara, Ray-Ban sunglasses and La Roche-Posay sun cream. In doing so, you have generated sales for Inditex, Essilor Luxottica and L'Oreal respectively. You may dine in a restaurant supplied with salmon from Mowi and beverages from Carlsberg. The desire to travel, consume and experience is the common denominator. Our belief is that this desire will be expressed with renewed fervour.

 

The Company's current investment positioning, then, can be summed up fairly simply: it is one which seeks to benefit from what we believe will be a happy confluence: an army of immunised consumers, armed with exceptionally high savings ratios. After a year or more of being unnaturally confined, the consumer is a coiled spring, ready to live life again. If we are right that not even a bungling European Union can prevent that, we can look forward to its powerful effects on our portfolio companies.

 

John Bennett and Tom O'Hara

Fund Managers

26 May 2021

 

 

Portfolio information as at 31 March 2021

Company

Sector

Country of listing

Valuation £'000

% of

portfolio

LafargeHolcim

Construction & Materials

Switzerland

24,849

7.2

UPM-Kymmene

Forestry & Paper

Finland

19,279

5.6

ASML

Technology Hardware & Equipment

Netherlands

14,499

4.2

Nestlé

Food Producers

Switzerland

12,562

3.6

ASR Nederland

Nonlife Insurance

Netherlands

12,003

3.5

Tessenderlo

Chemicals

Belgium

11,595

3.3

LVMH Moet Hennessy Louis Vuitton

Personal Goods

France

10,779

3.1

Roche

Pharmaceuticals & Biotechnology

Switzerland

9,350

2.7

Lundin Energy

Oil, Gas & Coal

Sweden

9,022

2.6

AKZO Nobel

Chemicals

Netherlands

9,014

2.6

 

 

 

-----------

------------

10 largest

 

 

132,952

38.4

 

 

 

-----------

------------

Signify

Electronic & Electrical Equipment

Netherlands

8,627

2.5

Sanofi

Pharmaceuticals & Biotechnology

France

8,505

2.5

Nordea Bank

Banks

Finland

8,320

2.4

STMicroelectronics

Technology Hardware & Equipment

France

8,207

2.4

Dometic

Leisure Goods

Sweden

7,906

2.3

BNP Paribas

Banks

France

7,732

2.2

Carlsberg

Beverages

Denmark

7,615

2.2

Autoliv

Automobiles & Parts

Sweden

7,600

2.2

Novartis

Pharmaceuticals & Biotechnology

Switzerland

7,473

2.2

Essilor Luxottica

Health Care Equipment & Services

France

7,413

2.1

 

 

 

-----------

------------

20 largest

 

 

212,350

61.4

 

 

 

-----------

------------

Mowi

Food Producers

Norway

7,289

2.1

Saint-Gobain

Construction & Materials

France

7,209

2.1

Deutsche Boerse

Financial Services

Germany

7,063

2.0

Airbus

Aerospace & Defence

France

6,799

1.9

Interpump

Industrial Engineering

Italy

6,770

1.9

Nokian Renkaat

Automobiles & Parts

Finland

6,769

1.9

Stellantis

Automobiles & Parts

Netherlands

6,104

1.8

Inditex

General Retailers

Spain

6,079

1.8

Daimler

Automobiles & Parts

Germany

5,748

1.7

ArcelorMittal

Industrial Metals & Mining

Netherlands

5,676

1.6

 

 

 

------------

------------

30 largest

 

 

277,856

80.2

 

 

 

------------

------------

Novo-Nordisk

Pharmaceuticals & Biotechnology

Denmark

5,492

1.6

Adidas

Personal Goods

Germany

5,404

1.6

L'Oreal

Personal Goods

France

5,384

1.6

Amadeus

Software & Computer Services

Spain

5,261

1.5

Enel

Electricity

Italy

5,247

1.5

Infineon

Technology Hardware & Equipment

Germany

5,116

1.5

KBC

Banks

Belgium

5,056

1.5

Engie

Gas Water & Multiutilities

France

4,522

1.3

Linde

Chemicals

Germany

4,345

1.3

Schneider Electric

Electronic & Electrical Equipment

France

3,984

1.2

40 largest

 

 

------------

327,667

-----------

-------------

94.8

------------

Bayer

Pharmaceuticals & Biotechnology

Germany

3,932

1.1

Metso

Industrial Engineering

Finland

3,828

1.1

Subsea 7

Oil, Gas & Coal

Norway

3,582

1.0

Ryanair

Travel & Leisure

Ireland

3,538

1.0

Volvo

Industrial Transportation

Sweden

3,379

1.0

 

 

------------

------------

Total investments at fair value

 

345,926

100.0

 

 

=======

=======

 

 

Country of listing (as a percentage of the portfolio excluding cash)

 

 

31 March 2021

%

31 March 2020

%

France

20.4

9.1

Netherlands

16.2

14.3

Switzerland

15.7

19.8

Finland

11.0

7.7

Germany

9.1

18.4

Sweden

8.1

11.3

Belgium

4.8

2.6

Denmark

3.8

4.8

Italy

3.5

3.4

Spain

3.3

4.2

Norway

3.1

1.4

Ireland

1.0

-

Portugal

-

1.7

United Kingdom

-

1.3

 

100.0

100.0

 

 

Sector exposure (as a percentage of the portfolio excluding cash)

 

 

31 March 2021

%

31 March 2020

%

Consumer discretionary

18.9

12.0

Industrials

18.9

21.0

Basic materials

14.4

10.5

Health Care

12.2

20.9

Financials

11.6

5.2

Technology

9.6

12.1

Consumer staples

8.0

8.9

Energy 

3.6

1.7

Utilities

2.8

5.0

Telecommunications

-

2.7

 

100.0

100.0

 

 

Principal Risks and Uncertainties

 

The principal risks and uncertainties associated with the Company's business can be divided into the following main areas:

 

·    Market

·    Investment performance

·    Business strategy and market rating

·    Gearing

·    Operational

·    Regulatory and reporting

 

Information on these risks and how they are managed is given in the Annual Report for the year ended 30 September 2020. In the view of the Board, these principal risks and uncertainties at the year-end remain and are as applicable to the remaining six months of the financial year as they were to the six months under review. 

 

There are a number of risks stemming from the Covid-19 pandemic and the uncertainty that this has created in global markets, both economically and politically, that may impact the operation of the Company, as referenced in the Chair's Statement. The Fund Managers will continue to review carefully the composition of the Company's portfolio and be proactive in taking investment decisions where necessary.  Janus Henderson (the "Manager") and the Company's other third-party service providers remain fully operational and have implemented appropriate business continuity plans to ensure that there has been no change in service while the majority of staff are working from home.

 

 

Related-Party Transactions

 

The Company's transactions with related parties in the period under review were with the directors and the Manager. There have been no material transactions between the Company and its directors during the period other than amounts paid to them in respect of expenses and remuneration for which there were no outstanding amounts payable at the period end.

 

In relation to the provision of services by the Manager, other than fees payable by the Company in the ordinary course of business and the facilitation of marketing activities with third parties, there have been no transactions with the Manager affecting the financial position of the Company during the period under review.

 

  

Statement of Directors' Responsibilities

 

The directors (as listed in note 13) confirm that, to the best of their knowledge:

 

(a)  the condensed financial statements for the half-year ended 31 March 2021 have been prepared in accordance with FRS 104

      Interim Financial Reporting, and give a true and fair view of the assets, liabilities, financial position and profit or loss of the

      Company;

 

(b)  the Interim Management Report and condensed financial statements include a fair review of the information required by

      Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months and description

      of principal risks and uncertainties for the remaining six months of the year); and

 

(c)  the Interim Management Report includes a fair review of the information required by the Disclosure Guidance and

      Transparency Rule 4.2.8R (disclosure of related-party transactions and changes therein).

  

 

For and on behalf of the Board

Vicky Hastings

Chair

26 May 2021
 

 

CONDENSED Income Statement

 

 

(Unaudited)

Half-year ended

31 March 2021

(Unaudited)

Half-year ended

31 March 2020

(Audited)

Year ended

30 September 2020

 

Revenue return £'000

Capital return £'000

Total return £'000

Revenue return

£'000

Capital return

£'000

Total return £'000

Revenue return £'000

Capital return £'000

Total return £'000

 

 

 

 

 

 

 

 

 

 

Gains/(losses) on investments held at fair value through profit or loss

-

40,694

40,694

-

(45,235)

(45,235)

-

15,146

15,146

 

 

 

 

 

 

 

 

 

 

Exchange gain/(loss) on currency transactions

-

9

9

-

(377)

(377)

-

(1,301)

(1,301)

 

 

 

 

 

 

 

 

 

 

Income from investments (note 2)

2,723

-

2,723

1,819

-

1,819

6,864

-

6,864

 

 

 

 

 

 

 

 

 

 

Other income

-

-

-

11

-

11

14

-

14

Gross revenue and capital gains/(losses)

2,723

40,703

43,426

1,830

(45,612)

(43,782)

6,878

13,845

20,723

 

 

 

 

 

 

 

 

 

 

Management fees (note 6)

(271)

(813)

(1,084)

(226)

(679)

(905)

(471)

(1,414)

(1,885)

Other fees and expenses

(284)

-

(284)

(256)

-

(256)

(506)

-

(506)

Net return/(loss) before finance costs and taxation

2,168

39,890

42,058

1,348

(46,291)

(44,943)

5,901

12,431

18,332

 

 

 

 

 

 

 

 

 

 

Finance costs

(36)

(92)

(128)

(47)

(123)

(170)

(105)

(285)

(390)

Net return/(loss) before taxation

2,132

39,798

41,930

1,301

(46,414)

(45,113)

5,796

12,146

17,942

 

 

 

 

 

 

 

 

 

 

Taxation on net return

(208)

-

(208)

(217)

-

(217)

(612)

-

(612)

Net return/(loss) after taxation

1,924

39,798

41,722

1,084

(46,414)

(45,330)

5,184

12,146

17,330

Return/(loss) per ordinary share (note 3)

9.00p

186.12p

195.12p

5.04p

(215.90p)

(210.86p)

24.13p

56.54p

80.67p

 

The total columns of this statement represent the Income Statement of the Company prepared in accordance with FRS 104.

 

The revenue return and capital return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.  

 

All revenue and capital items in the above statement derive from continuing operations. The Company had no recognised gains or losses other than those disclosed in the Income Statement and the Statement of Changes in Equity.

 

The accompanying notes are an integral part of the condensed financial statements.           

 

 

CONDENSED Statement of Changes in Equity

Half-year ended 31 March 2021
(Unaudited)
 
Called-up
share

capital

£'000

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 
Merger reserve £'000
 
Capital redemption
reserve

£'000

 

 
Capital reserve

£'000

Revenue reserve

£'000

Total

shareholders' funds

£'000

At 30 September 2020

10,819

25,846

41,995

61,344

9,421

148,714

10,027

308,166

Net return after taxation

-

-

-

-

-

39,798

1,924

41,722

Ordinary dividend paid

-

-

-

-

-

-

(4,640)

(4,640)

Unclaimed dividends over 12 years old

-

-

-

-

-

-

81

At 31 March 2021

10,819

25,846

41,995

61,344

9,421

188,512

7,392

345,329

Half-year ended 31 March 2020
(Unaudited)
 
 
Called-up
share

capital

£'000

 

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 

 
Merger reserve £'000
 
Capital redemption
reserve

£'000

 

 
Capital reserve

£'000

Revenue reserve

£'000

At 30 September 2019

10,819

25,846

41,995

61,344

9,421

138,013

11,572

299,010

Net (loss)/return after taxation

-

-

-

-

-

(46,414)

1,084

(45,330)

Ordinary dividend paid

-

-

-

-

-

-

(4,665)

(4,665)

At 31 March 2020

10,819

25,846

41,995

61,344

9,421

91,599

7,991

249,015

Year ended 30 September 2020
(Audited)
 
 
Called-up
share

capital

£'000

 

 

Special

distributable

reserve

£'000

Share premium account £'000

 

 

 

 
Merger reserve £'000
 
Capital redemption
reserve

£'000

 

 
Capital reserve

£'000

Revenue reserve

£'000

At 30 September 2019

10,819

25,846

41,995

61,344

9,421

138,013

11,572

299,010

Net return after taxation

-

-

-

-

-

12,146

5,184

17,330

Buyback of ordinary shares for treasury

-

-

-

-

-

(1,.445)

-

(1,445)

Ordinary dividend paid

-

-

-

-

-

-

(6,729)

At 30 September 2020

10,819

25,846

41,995

61,344

9,421

148,714

10,027

308,166

  

The accompanying notes are an integral part of the condensed financial statements.

 

 

CONDENSED Statement of Financial Position

 

 

(Unaudited)

31 March

2021

            £'000

(Unaudited)

31 March

2020

            £'000

(Audited)

30 September

2020

            £'000

Fixed assets

 

 

 

Investments held at fair value through profit or loss

345,926

254,160

309,882

 

 

 

 

Current assets

 

 

 

Debtors

3,948

11,038

5,898

Cash at bank

55

18,174

34,345

 

4,003

29,212

40,243

 

 

 

 

Creditors: amounts falling due within one year

(4,600)

(34,357)

(41,959)

 

 

 

 

Net current liabilities

(597)

(5,145)

(1,716)

 

 

 

 

Net assets

345,329

249,015

308,166

 

 

 

 

Capital and reserves

 

 

 

Called-up share capital

10,819

10,819

10,819

Special distributable reserve

25,846

25,846

25,846

Share premium account

41,995

41,995

41,995

Merger reserve

61,344

61,344

61,344

Capital redemption reserve

9,421

9,421

9,421

Capital reserve

188,512

91,599

148,714

Revenue reserve

7,392

7,991

10,027

Total shareholders' funds

345,329

249,015

308,166

 

 

 

 

Net asset value per ordinary share (note 5)

1,615.00p

1,158.30p

1,441.20p

 

The accompanying notes are an integral part of the condensed financial statements.

 

 

CONDENSED Cash Flow Statement

 

(Unaudited)

Half-year ended

31 March

2021

£'000

(Unaudited)

Half-year ended

31 March

2020

£'000

(Audited)

Year ended 

30 September

2020

£'000

Cash flows from operating activities

 

 

 

Net return/(loss) before taxation

41,930

(45,113)

17,942

Add back: finance costs

128

170

390

(Gains)/losses on investments held at fair value through profit or loss

(40,694)

45,235

(15,146)

(Gains)/losses on foreign exchange

(9)

377

1,301

Taxation paid

(264)

(172)

(802)

(Increase)/decrease in debtors

(1,068)

25

(10)

(Decrease)/increase in creditors

(405)

(565)

338

Net cash (outflow)/inflow from operating activities

(382)

(43)

4,013

Cash flows from investing activities

 

 

 

Sales of investments held at fair value through profit or loss

194,731

116,268

261,275

Purchases of investments held at fair value through profit or loss

(190,990)

(114,808)

(245,374)

Net cash inflow from investing activities

3,741

1,460

15,901

Cash flows from financing activities

 

 

 

Buyback of shares for treasury

-

-

(1,445)

Equity dividends paid (net of refund of unclaimed distributions)

(4,559)

(4,665)

(6,729)

(Repayment)/drawdown of bank overdraft

(32,921)

10,147

12,448

Interest paid

(178)

(155)

(349)

Net cash (outflow)/inflow from financing activities

(37,658)

5,327

3,925

Net (decrease)/increase in cash and cash equivalents

(34,299)

6,744

23,839

Cash and cash equivalents at beginning of period

34,345

11,807

11,807

Gains/(losses) foreign exchange

9

(377)

(1,301)

Cash and cash equivalents at end of period

55

18,174

34,345

Comprising:

 

 

 

Cash at bank

55

18,174

34,345

 

The accompanying notes are an integral part of these financial statements

 

 

Notes to the condensed financial statements

 

1.

 

The condensed set of financial statements has been prepared in accordance with FRS 104, Interim Financial Reporting, FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland and the Statement of Recommended Practice for "Financial Statements of Investment Trust Companies and Venture Capital Trusts", which was updated by the Association of Investment Companies in October 2019.

 

For the period under review the Company's accounting policies have not varied from those described in the Annual Report for the year ended 30 September 2020.  The condensed set of financial statements has been neither audited nor reviewed by the Company's auditor.

 

 

2.

Income from investments

 

 

(Unaudited)

Half-year ended

31 March

2021

£'000

(Unaudited)

Half-year ended

31 March

2020

£'000

 

(Audited)

Year ended

30 September 2020

£'000

Listed investments:

 

 

 

Overseas dividends

2,723

1,712

6,730

UK dividends

-

107

134

 

2,723

1,819

6,864

 

 

 

 

 

3.

Return/(loss) per ordinary share

 

 

(Unaudited)

Half-year ended

31 March 2021

£'000

(Unaudited)

Half-year ended

31 March 2020

£'000

(Audited)

Year ended

30 September 2020

 £'000

The return per ordinary share is based on the following figures:

 

 

 

Net revenue return

1,924

1,084

5,184

Net capital return/(loss)

39,798

(46,414)

12,146

Net total return/(loss)

41,722

(45,330)

17,330

 

 

 

 

Weighted average number of ordinary shares in issue for each period

21,382,578

21,498,261

21,480,288

 

 

 

 

Revenue return per ordinary share

9.00p

5.04p

24.13p

Capital return/(loss) per ordinary share

186.12p

(215.90)p

56.54p

Total return/(loss) per ordinary share

195.12p

(210.86)p

80.67p

 

The Company has no securities in issue that could dilute the return per ordinary share. Therefore, the basic and diluted returns per share are the same.

 

 

4.

Called-up share capital

 

At 31 March 2021, there were 21,638,991 shares in issue, of which 256,413 were held in treasury. During the half-year period ended 31 March 2021, no shares were issued or repurchased (half-year ended 31 March 2020: no shares issued or repurchased, year ended 30 September 2020: 115,683 shares repurchased at a cost of £1,445,000). No shares have been issued or repurchased since 31 March 2021. As at 26 May 2021, 21,382,578 shares were entitled to a dividend.

 

 

5.

Net asset value per ordinary share - basic and diluted

 

The net asset value per ordinary share is based on the 21,382,578 ordinary shares in issue (excluding treasury shares) at 31 March 2021 (half-year ended 31 March 2020: 21,498,261, year ended 30 September 2020: 21,382,578). 

 

 

6.

Management fees

 

Henderson Investment Funds Limited ("HIFL") is appointed to act as the Company's alternative investment fund manager. HIFL delegates investment management services to Henderson Global Investors Limited ("HGIL"). References to Janus Henderson or the Manager within these results refer to the services provided by both HIFL and HGIL.

 

Management fees are charged in accordance with the terms of the management agreement. The Manager receives a fee of 0.65% per annum of net assets up to £300m and 0.55% of net assets above £300m. Any holdings in funds managed by Janus Henderson are excluded from the calculation of the management fee. There is no performance fee.

 

Management fees and finance costs are allocated 25% to revenue and 75% to capital in the Condensed Income Statement.

 

 

7.

Investments held at fair value through profit or loss

 

The table below analyses fair value measurements for investments held at fair value through profit or loss. These fair value measurements are categorised into different levels in the fair value hierarchy based on the valuation techniques used and are defined as follows under FRS 102:

 

Level 1:  the unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date.

Level 2:  inputs other than quoted prices included within Level 1 that are observable (i.e. developed using market data) for the asset or liability, either directly or indirectly.

Level 3:   inputs are unobservable (i.e. for which market data is unavailable) for the asset or liability.

 

Financial assets held at fair value through profit or loss at 31 March 2021

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

345,926

-

-

345,926

Total

345,926

-

-

345,926

 

 

Financial assets held at fair value through profit or loss at 31 March 2020

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

254,160

-

-

254,160

Total

254,160

-

-

254,160

 

Financial assets held at fair value through profit or loss at 30 September 2020

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Quoted equities

309,882

-

-

309,882

Total

309,882

-

-

309,882

 

There have been no transfers between levels of fair value hierarchy during the period.

 

 

The valuation techniques used by the Company are explained in the accounting policies note 1(c) in the Company's Annual Report for the year ended 30 September 2020.

 

8.

Borrowings

 

As at 31 March 2021, the Company's bank overdraft included in 'Creditors: amounts falling due within one year' was £2,576,000 (31 March 2020: £33,196,000; 30 September 2020: £35,497,000).

 

9.

Changes in net debt

 

The following table shows the movements during the period of net debt in the statement of financial position:

 

 

 

At 1 October 2020

£'000

Cash flows

£'000

Non-cash changes

Foreign exchange movement

 £'000

At 31 March 2021

£'000

Financing Activities

 

 

 

 

Bank overdraft

(35,497)

32,921

-

(2,576)

 

(35,497)

32,921

-

(2,576)

Non-financing Activities

 

 

 

 

Cash and cash equivalents

34,345

(34,299)

9

55

 

34,345

(34,299)

9

55

Total

(1,152)

(1,378)

9

(2,521)

 

 

 

At 1 October 2019

£'000

Cash flows

£'000

Non-cash changes

Foreign exchange movement

 £'000

At 31 March 2020

£'000

Financing Activities

 

 

 

 

Bank overdraft

(23,049)

(10,147)

-

(33,196)

 

(23,049)

(10,147)

-

(33,196)

Non-financing Activities

 

 

 

 

Cash and cash equivalents

11,807

6,744

(377)

18,174

 

11,807

6,744

(377)

18,174

Total

(11,242)

(3,403)

(377)

(15,022)

 

 

At 1 October 2019

£'000

Cash flows

£'000

Non-cash changes

Foreign exchange movement

 £'000

At 30 September 2020

£'000

Financing Activities

 

 

 

 

Bank overdraft

(23,049)

(12,448)

-

(35,497)

 

(23,049)

(12,448)

-

(35,497)

Non-financing Activities

 

 

 

 

Cash and cash equivalents

11,807

23,839

(1,301)

34,345

 

11,807

23,839

(1,301)

34,345

Total

(11,242)

11,391

(1,301)

(1,152)

 

 

10.

Going concern

 

The assets of the Company consist of securities that are readily realisable and, accordingly, the directors believe that the Company has adequate resources to continue in operational existence for at least twelve months from the date of approval of these financial statements. Having assessed these factors and the principal risks, as well as considering the additional risks related to Covid-19, the directors consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements.

 

11.

Dividends

 

The directors have declared an interim dividend of 9.60p per ordinary share (2020: 9.60p), payable on 25 June 2021 to shareholders on the register on 4 June 2021. The shares will be quoted ex-dividend on 3 June 2021.  Based on the 21,382,578 ordinary shares in issue (excluding treasury shares) as at 26 May 2021, the cost of this dividend will be £2,053,000 (2020 interim dividend: £2,064,000).

 

 

12.

Comparative information

 

The financial information contained in this half-year report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The financial information for the half-years ended 31 March 2021 and 31 March 2020 has not been audited or reviewed by the Company's auditor. The figures and financial information for the year ended 30 September 2020 are an extract based on the latest published accounts and do not constitute statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the Independent Auditor's Report which was unqualified and did not contain a statement under either s498(2) or s498(3) Companies Act 2006. A glossary of terms and details of alternative performance measures can be found in the Annual Report for the year ended 30 September 2020.

 

 

13.

General information

 

Company status

Henderson European Focus Trust plc is registered in England and Wales (no. 00427958), has its registered office at 201 Bishopsgate, London EC2M 3AE and is listed on the London Stock Exchange. 

 

SEDOL/ISIN: 0526885/GB0005268858

London Stock Exchange ("TIDM") code: HEFT

Global Intermediary Identification Number ("GIIN"): THMNPN.99999.SL.826

Legal Entity Identifier ("LEI") number: 213800GS89AL1DK3IN50

 

 

Directors and secretary

The directors of the Company are Vicky Hastings (Chair), Eliza Dungworth (Chair of the Audit and Risk Committee) and Robin Archibald (Senior Independent Director). The corporate secretary is Henderson Secretarial Services Limited.

 

 

Website

Details of the Company's share price and net asset value, together with general information about the Company, monthly factsheets and data, copies of announcements, reports and details of general meetings can be found at www.hendersoneuropeanfocus.com.

 

 

14.

Half-year report

 

The half-year report will shortly be available on the Company's website or from the Company's registered office. An abbreviated version, the 'Update', will be posted to shareholders in June 2021. The Update will also be posted on the Company's website, and hard copies will be available from the Company's registered office.

 

 

 

 

For further information, please contact:

 

Vicky Hastings

Chair of the Board

Henderson European Focus Trust

Tel: 020 7818 2220

 

James de Sausmarez

Director and Head of Investment Trusts

Janus Henderson Investors

Tel: 020 7818 3349

Laura Thomas

Investment Trust PR Manager

Janus Henderson Investors

Tel: 020 7818 2636

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) are incorporated into, or form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFSSETIRFIL
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Henderson European Focus Trust PLC (HEFT)

+2.00p (+1.11%)
delayed 15:49PM